Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2015-05-11

FDA Approved: TESTIM — Supplemental Application (Endo USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for TESTIM (testosterone gel) from Endo USA, Inc., triggering a change to the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TESTIM (TESTOSTERONE)

Snippet

SUPPL AP for TESTIM (TESTOSTERONE)